Pharmacists: Bispecifics and Operational Role : vimarsana.co

Robert Mancini, PharmD, reviews pharmacists’ pivotal role in operationalizing use of bispecifics in diffuse large B-cell lymphoma (DLBCL), overcoming challenges, and supporting direct patient care teams.

Related Keywords

Robert Mancini , Zahra Mahmoudjafari , Aamir Ali , , Practice Pearls , Bispecific Antibodies , Dlbcl , Clinical Trials , Epcorinomab , Glofitomab , Approval , Response Rates , Duration Of Response , Progression Free Survival , Toxicity Profiles , Crs , Neurotoxicity , Trial Design , Patient Cohorts , Biospecific Treatments , Lymphoma Therapy , Step Up Dosing , Outpatient Administration , Patient Education , Side Effect Management , Treatment Pathways , Institutional Preferences , Decision Making Processes , Immunotherapy Options , Side Effect Correlation , Reatment Adaptation , Response Assessment , Tumor Flare Monitoring ,